Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
McKinsey
Mallinckrodt
Boehringer Ingelheim
McKesson

Last Updated: December 3, 2021

DrugPatentWatch Database Preview

Patent: 9,315,811

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,315,811
Title:Methods for modulating kallikrein (KLKB1) expression
Abstract: Disclosed herein are methods for decreasing kallikrein and treating or preventing inflammatory conditions in an individual in need thereof. Examples of disease conditions that can be ameliorated with the administration of antisense compounds targeted to kallikrein include hereditary angioedema (HAE). Methods for inhibiting kallikrein can also be used as a prophylactic treatment to prevent individuals at risk for developing an inflammatory condition, such as, hereditary angioedema.
Inventor(s): Bhattacharjee; Gourab (San Diego, CA), Revenko; Alexey (San Diego, CA), MacLeod; Robert A. (San Diego, CA)
Assignee: Ionis Pharmaceuticals, Inc. (Carlsbad, CA)
Application Number:14/124,630
Patent Claims:see list of patent claims

Details for Patent 9,315,811

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Viropharma Biologics Llc CINRYZE c1 esterase inhibitor (human) For Injection 125267 2008-10-10 ⤷  Try it Free 2031-06-10
Takeda Pharmaceuticals U.s.a., Inc. KALBITOR ecallantide Injection 125277 2009-12-01 ⤷  Try it Free 2031-06-10
Csl Behring Gmbh BERINERT c1 esterase inhibitor (human) For Injection 125287 2009-10-09 ⤷  Try it Free 2031-06-10
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Colorcon
Boehringer Ingelheim
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.